Wilson Martin sold 75,364 Rocket Pharmaceuticals shares at $3.40 per share on 2026-09-11, a transaction equal to about 11.2% of his prior holding. For investors, the disclosed transaction leaves Martin with 598,489 shares and identifies the scale of the sale relative to his own position.

Key Highlights

  • Martin is identified as Rocket Pharmaceuticals’ general counsel.
  • His post-transaction holding was 598,489 shares.
  • The filing lists SEC transaction code S.

Wilson Martin sold 75,364 Rocket Pharmaceuticals shares at $3.40 per share on 11 September 2026, in a transaction representing about 11.2% of his prior holding.

General Counsel’s Share Sale

Martin is identified as general counsel of Rocket Pharmaceuticals. The filing lists SEC transaction code S. The reported transaction involved Rocket Pharmaceuticals shares and was dated 11 September 2026. The per-share price was $3.40, while the disclosed transaction quantity was 75,364 shares.

Post-Transaction Holding

Martin owned 598,489 shares after the transaction. The filing states that the transaction represented about 11.2% of his prior shareholding. Transaction code S denotes an open-market or private sale.